Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Becton Dickinson and Company 1 BECTON DRIVE FRANKLIN LAKES NJ 07417 USA

P: 201-847-6800

Description:

Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.

Key Statistics

Overview:

Market Capitalization, $K 67,805,232
Shares Outstanding, K 269,732
Annual Sales, $ 15,983 M
Annual Net Income, $ 311,000 K
Last Quarter Sales, $ 4,195 M
Last Quarter Net Income, $ 20,000 K
60-Month Beta 1.12
% of Insider Shareholders 0.12%
% of Institutional Shareholders 84.54%
Float, K 269,408
% Float 99.88%

Growth:

1-Year Return 1.65%
3-Year Return 45.02%
5-Year Return 112.77%
5-Year Revenue Growth 98.45%
5-Year Earnings Growth 85.04%
5-Year Dividend Growth 51.52%

Per-Share Information:

Most Recent Earnings 2.59 on 05/09/19
Next Earnings Date 08/06/19
Earnings Per Share ttm 11.13
EPS Growth vs. Prev Qtr -4.07%
EPS Growth vs. Prev Year -2.26%
Annual Dividend Rate, $ 3.08
Annual Dividend Yield 1.23%
Most Recent Dividend 0.770 on 06/06/19
Next Ex-Dividends Date 06/06/19
Dividend Payable Date 06/28/19
Dividend Payout Ratio 26.34
Most Recent Split 2-1 on 08/21/98

BDX Ratios

Ratio
Price/Earnings ttm 22.75
Price/Earnings forward 20.44
Price/Earnings to Growth 1.87
Return-on-Equity (After Tax) 14.58
Return-on-Assets (Before Tax) 5.81
Profit Margin % 1.95
Net Margin % 17.88
Debt/Equity 0.82
Price/Sales 4.27
Price/Cash Flow 13.89
Price/Book 3.21
Book Value/Share 79.00
Interest Coverage 2.66

BDX Dividends

Date Value
06/06/19 $0.7700
03/07/19 $0.7700
12/07/18 $0.7700
09/06/18 $0.7500
06/07/18 $0.7500
03/08/18 $0.7500
12/07/17 $0.7500
09/07/17 $0.7300
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar